NSI Retail Advisors’s Pfizer PFE Stock Holding History

NSI Retail Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,869	Closed	-$362K	–	47
2023 Q2	$362K	Sell	9,869 -500	-5%	-$19.5K	0.06%	41
2023 Q1	$423K	Hold	10,369	–	–	0.09%	35
2022 Q4	$531K	Hold	10,369	–	–	0.12%	30
2022 Q3	$454K	Hold	10,369	–	–	0.13%	27
2022 Q2	$544K	Hold	10,369	–	–	0.12%	26
2022 Q1	$537K	Hold	10,369	–	–	0.08%	37
2021 Q4	$612K	Hold	10,369	–	–	0.1%	36
2021 Q3	$446K	Hold	10,369	–	–	0.08%	40
2021 Q2	$406K	Buy	+10,369	New	+$403K	0.06%	49

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

NSI Retail Advisors's PFE Position: Q3 2023 in Review

NSI Retail Advisors sold out of Pfizer (PFE) in Q3 2023, closing a stake of 9,869 shares — an estimated $362K sold.

NSI Retail Advisors first reported a position in PFE in Q2 2021 and held it in 9 quarters. The position peaked at $612K in Q4 2021. 2,928 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

NSI Retail Advisors reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
NSI Retail Advisors sold 9,869 Pfizer shares in Q3 2023, an estimated $362K.
NSI Retail Advisors first reported a position in Pfizer in Q2 2021 and held it in 9 quarters.
NSI Retail Advisors's Pfizer position peaked at $612K in Q4 2021.
2,928 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on NSI Retail Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.